コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ients (236 autologous, 128 reduced-intensity allogeneic, 113 myeloablative allogeneic) underwent stan
2 ety and efficacy of autologous (auto) versus allogeneic (allo) bone marrow-derived hMSCs in NIDCM.
4 e Washington State residents (n = 1,792; 52% allogeneic and 90% hematologic malignancies) were freque
7 immune-stimulatory molecules including semi-allogeneic antigens from maternal cells, substances from
8 r, they differ markedly in their response to allogeneic antigens, strongly promoting regulatory T-cel
11 treat graft-versus-host disease (GVHD) after allogeneic blood or marrow transplantation (alloBMT) put
12 es assessed the association of perioperative allogeneic blood transfusion, sepsis, and 5-year colon c
15 Here, we demonstrate, using murine models of allogeneic BMT, that type 2 innate lymphoid cells (ILC2s
16 10/Fc, TGF-beta/Fc, or IL-2/Fc would enhance allogeneic bone marrow cell (BMC) engraftment and promot
18 reconstitution and thymus regeneration after allogeneic bone marrow nucleated cell transplantation bu
20 sm and allograft tolerance in mice receiving allogeneic bone marrow transplant (BMT) with minimal con
24 is a major cause of late mortality following allogeneic bone marrow transplantation (BMT) and is char
26 ompare the safety and efficacy of 2 doses of allogeneic bone marrow-derived human mesenchymal stem ce
27 hough the efficiency of diabetes reversal of allogeneic but not syngeneic CC islets was lower than th
28 erentiated derivatives are not recognized as allogeneic by CD8(+) T cells, do not bind anti-HLA antib
32 represents a novel experience in humans with allogeneic cardiac stem cell in a rigorously imaging-bas
33 hether post-MI transendocardial injection of allogeneic CBSCs reduces pathological structural and fun
35 and iDDC had a reduced ability to stimulate allogeneic CD4(+) T cells in the mixed-lymphocyte reacti
37 progenitor cells are a bone marrow-derived, allogeneic, cell therapy product that modulates the immu
40 lecular patterns have been well defined, how allogeneic cellular stimuli evoke innate responses remai
41 te prolonged and high levels of multilineage allogeneic chimerism and robust tolerance to the donor.
46 ects extensive genetic polymorphisms between allogeneic donors and recipients, most prominently withi
47 f intranodal administration of autologous or allogeneic DRibbles together with anti-OX40 antibody led
48 ling evidence that these cells can recognize allogeneic entities and that they mediate graft rejectio
50 d safety of a single local administration of allogeneic expanded adipose-derived stem cells (Cx601) i
53 esults provide new mechanistic insights into allogeneic GVT, validate the importance of targeting the
55 potential long-term neurological benefit of allogeneic haematopoietic stem cell transplantation in a
56 t cerebral adrenoleukodystrophy treated with allogeneic haematopoietic stem cell transplantation on a
60 of multiple dsDNA viruses was frequent after allogeneic HCT and had a dose-dependent association with
61 ipient pairs (8638 subjects) who received an allogeneic HCT and had archived pre-HCT peripheral blood
62 spectively tested weekly plasma samples from allogeneic HCT recipients at our center from 2007 to 201
67 gic malignancies who underwent autologous or allogeneic HCT to inpatient palliative care integrated w
68 center cohorts, with clinical outcomes after allogeneic HCT within this prospective, multicenter stud
74 ronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplant (HCT) conferred
77 ins a major life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT)
79 se (GVHD), which is the main complication of allogeneic hematopoietic cell transplantation (allo-HCT)
80 f graft-versus-host disease (GVHD) following allogeneic hematopoietic cell transplantation (allo-HCT)
81 in double-stranded DNA (dsDNA) viruses after allogeneic hematopoietic cell transplantation (HCT) are
83 t-versus-host disease (GVHD) is higher after allogeneic hematopoietic cell transplantation (HCT) from
84 Purpose The optimal regimen intensity before allogeneic hematopoietic cell transplantation (HCT) is u
85 ase (GVHD) prophylaxis after matched-related allogeneic hematopoietic cell transplantation (HCT) rece
87 t-versus-host disease (GVHD) is common after allogeneic hematopoietic cell transplantation (HCT).
89 t cause of morbidity and mortality following allogeneic hematopoietic cell transplantation (HCT).
90 rment is well-recognized after myeloablative allogeneic hematopoietic cell transplantation (HCT).
91 treatment options for relapsed lymphoma post-allogeneic hematopoietic cell transplantation (post-allo
93 yclophosphamide-based haploidentical (HAPLO) allogeneic hematopoietic cell transplantation with the o
95 safety and immunogenicity results of MVA in allogeneic hematopoietic stem cell transplant (HCT) reci
97 megalovirus (CMV) retinitis in the pediatric allogeneic hematopoietic stem cell transplant (HSCT) pop
98 is a respiratory virus detected in >/=9% of allogeneic hematopoietic stem cell transplant (HSCT) rec
99 with increased morbidity and mortality after allogeneic hematopoietic stem cell transplant (HSCT).
100 ry bowel disease (IBD), and poor survival in allogeneic hematopoietic stem cell transplant recipients
101 f PIV3-specific T cells and viral control in allogeneic hematopoietic stem cell transplant recipients
102 onic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplant reflects a
103 mune responses can eradicate lymphomas after allogeneic hematopoietic stem cell transplantation (AHSC
104 is a frequent complication in recipients of allogeneic hematopoietic stem cell transplantation (allo
105 immunity, have been successfully treated by allogeneic hematopoietic stem cell transplantation (Allo
107 major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo
108 ental graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo
109 e of adult intestinal toxemia botulism in an allogeneic hematopoietic stem cell transplantation (allo
110 The graft-versus-leukemia (GVL) effect in allogeneic hematopoietic stem cell transplantation (allo
111 ngiogenesis has not been investigated during allogeneic hematopoietic stem cell transplantation (allo
112 Leukemia relapse remains the major cause of allogeneic hematopoietic stem cell transplantation (HCT)
113 e a frequent and devastating complication of allogeneic hematopoietic stem cell transplantation (HSCT
114 mes Foundation developed recommendations for allogeneic hematopoietic stem cell transplantation (HSCT
115 of morbidity and mortality in patients after allogeneic hematopoietic stem cell transplantation (HSCT
116 t important cause of treatment failure after allogeneic hematopoietic stem cell transplantation (HSCT
117 pstein-Barr virus (EBV) infections following allogeneic hematopoietic stem cell transplantation (HSCT
118 solid-organ transplants, virome dynamics in allogeneic hematopoietic stem cell transplantation (HSCT
119 relies largely on intensive chemotherapy and allogeneic hematopoietic stem cell transplantation (HSCT
122 sus-host disease (GVHD) is a complication of allogeneic hematopoietic stem cell transplantation (HSCT
126 e antigen (anti-HBc)-positive patients after allogeneic hematopoietic stem cell transplantation (HSCT
127 sease (cGVHD) is a notorious complication of allogeneic hematopoietic stem cell transplantation and c
128 th advanced systemic mastocytosis, including allogeneic hematopoietic stem cell transplantation and m
129 Clinical outcomes for patients undergoing allogeneic hematopoietic stem cell transplantation conti
130 rvival rates in patients treated early after allogeneic hematopoietic stem cell transplantation do no
131 s (PIDs) have been successfully treated with allogeneic hematopoietic stem cell transplantation for m
132 ent with acute myeloid leukemia who received allogeneic hematopoietic stem cell transplantation from
135 stress syndrome but has not been assessed in allogeneic hematopoietic stem cell transplantation recip
139 l membrane oxygenation within 240 days after allogeneic hematopoietic stem cell transplantation survi
141 ell-mediated graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, sugg
142 se-free survival may only be achievable with allogeneic hematopoietic stem cell transplantation.
143 s syndrome is a frequent condition following allogeneic hematopoietic stem cell transplantation.
144 n animal models of virally triggered IBD and allogeneic hematopoietic stem cell transplantation.
145 146 (interquartile range, 27-321) days after allogeneic hematopoietic stem cell transplantation.
146 ted with immune suppressants, etoposide, and allogeneic hematopoietic stem cell transplantation; more
149 ment of cure rates for patients treated with allogeneic hematopoietic stem-cell transplantation (HSCT
150 t molecular subgroups of patients undergoing allogeneic hematopoietic stem-cell transplantation for M
151 yeloid leukemia (AML) can only be cured when allogeneic hematopoietic stem-cell transplantation induc
153 d minimal residual disease response, rate of allogeneic hematopoietic stem-cell transplantation, rela
155 utations may predict clinical outcomes after allogeneic hematopoietic stem-cell transplantation.
158 Purpose The major causes of mortality after allogeneic hematopoietic-cell transplantation (allo-HCT)
160 t reactivity with myeloma patient sera after allogeneic HSCT and that may be significantly translocat
161 ge cerebral disease who were treated with an allogeneic HSCT and to identify disease- and treatment-r
162 pha-L-iduronidase, and patients treated with allogeneic HSCT at the onset have improved outcome, sugg
163 n's Hospital of Colorado (CHCO) who received allogeneic HSCT between January 2010 and December 2014.
164 ho were at least 16 years old, had undergone allogeneic HSCT for a hematological malignancy, and had
167 These results establish a new preclinical allogeneic HSCT model for evaluation of GvHD prophylaxis
168 is significantly upregulated in the serum of allogeneic HSCT patients at aGVHD onset compared with no
169 recent cluster of CMV retinitis in pediatric allogeneic HSCT patients may suggest a rise in incidence
173 tive to enzyme replacement therapy (ERT) and allogeneic HSCT that has shown clinical benefit for aden
174 atients with undetectable HBV DNA undergoing allogeneic HSCT were prospectively monitored every 4 wee
175 Both patients were successfully treated with allogeneic HSCT with sustained reconstitution of hematop
176 ts had a high rate of HBV reactivation after allogeneic HSCT, with determinants of HBV reactivation i
179 2014 to December 2014, 28 patients underwent allogeneic HSCT; 13 patients (46%) had CMV viremia, not
180 epidemiology of pre-engraftment GNB in 1118 allogeneic HSCTs (allo-HSCTs) and 1625 autologous HSCTs
181 y, and efficacy of intracoronary delivery of allogeneic human cardiac stem cell in 55 patients with l
182 rica to determine the safety and efficacy of allogeneic human mesenchymal stem cells (MSCs) in reduci
183 ther 20 million (n=15) or 100 million (n=15) allogeneic human mesenchymal stem cells via transendocar
184 the reverse was true when the autologous and allogeneic IgG concentrations were augmented in allograf
186 text, we were able to visualize differential allogeneic immune synapse formation in polyclonal CD4(+)
187 In contrast, the vasculature of DSA-exposed allogeneic islet grafts was devoid of lesions because sp
189 in MicroMix capsules improved engraftment of allogeneic islets in the IP site, but resulted deleterio
193 r-lateral left ventricular wall in C57BL/6J (allogeneic model, n = 17) and C3H (syngeneic model, n =
197 nt here a randomized, controlled trial using allogeneic MSC, which are logistically more convenient t
198 AKI after cardiac surgery, administration of allogeneic MSCs did not decrease the time to recovery of
200 jor histocompatibility complex (MHC)-matched allogeneic neural cell grafting in the brain, which is c
201 ZA) and decitabine (DAC) in combination with allogeneic NK cells generated from CD34(+) hematopoietic
206 were collected from draining lymph nodes of allogeneic or syngeneic corneal transplanted BALB/c mice
207 hestrate immune responses and destruction of allogeneic organ transplants, but how this process is re
209 -mediated skin injury caused by transferring allogeneic peripheral blood mononuclear cells more effec
211 hronic disease complications and for whom an allogeneic procedure could present an unacceptable risk.
216 e either the freshest available, compatible, allogeneic red cells (short-term storage group) or stand
217 analysis using the Luminex platform, T cell allogeneic responses were measured by flow cytometry, an
218 e IDO-1 score (p = 0.007) and not undergoing allogeneic SCT (p = 0.007) was found to significantly pr
222 of platelet counts among patients undergoing allogeneic SCT or chemotherapy and because platelet tran
223 assess prognostic factors of survival in all allogeneic SCT recipients admitted to the ICU between 20
229 d primary human B cells as well as in murine allogeneic skin transplant and alloantigen-induced T cel
230 esponses to allogeneic stimulation in vitro, allogeneic splenocyte immunization in vivo, and allogene
232 with leukemia who receive a T cell-depleted allogeneic stem cell graft followed by postponed donor l
234 IDO-1 score (p < 0.0001) and not undergoing allogeneic stem cell transplant (SCT, p = 0.0005) predic
235 ents, 4 received consolidative hematopoietic allogeneic stem cell transplant, and 9 (9% of all enroll
237 Chronic graft-vs-host-disease (cGVHD) after allogeneic stem cell transplantation (AHSCT) may resembl
238 ng 1 documented case of HIV-1 cure following allogeneic stem cell transplantation (allo-SCT), several
241 1m MRD may be used as a predictive factor of allogeneic stem cell transplantation (ASCT) benefit.
243 ge and after censoring patients who received allogeneic stem cell transplantation (SCT) in first remi
246 consider additional studies and referral for allogeneic stem cell transplantation are also discussed.
249 e of pathological immune responses following allogeneic stem cell transplantation resulting in acute
250 nitored 39 children shortly before and after allogeneic stem cell transplantation twice weekly by use
251 disease (cGVHD) is a serious complication of allogeneic stem cell transplantation with few effective
252 123) and DC-SIGN (rs11465384 and rs7248637), allogeneic stem cell transplantation, respiratory virus
253 nogenic significance after HLA 10/10 matched allogeneic stem cell transplantation, we show that in th
257 elevated bleeding risk in patients receiving allogeneic stem cell transplants (SCTs) or chemotherapy
259 first remission and no identified donor for allogeneic stem-cell transplantation (SCT) were eligible
260 MRI, had withdrawn from the study to undergo allogeneic stem-cell transplantation and later died from
261 ; 95% CI, 58.7% to 73.2%; P = 0.33) and that allogeneic stem-cell transplantation had a beneficial ef
262 y may be a safe and effective alternative to allogeneic stem-cell transplantation in boys with early-
268 ced obesity and assessed immune responses to allogeneic stimulation in vitro, allogeneic splenocyte i
269 D70 serves as a unique negative regulator of allogeneic T cell response by contributing to donor T ce
270 ing role of BECs in a human ex vivo model of allogeneic T cell response, both in healthy subjects and
271 CD1(-) cDC were superior in stimulating allogeneic T cell responses and in cross-presenting vira
273 among patients in their ability to suppress allogeneic T cells and in the use of either IL-17/argina
277 teins enabling subsequent ex vivo priming of allogeneic T cells with a specific cytokine signature.
279 Collectively, our data implicate Cdk5 in allogeneic T-cell responses after HCT and as an importan
285 nomodulation may underlie the association of allogeneic transfusion with increased perioperative morb
286 rogate for NETs in 103 consecutive pediatric allogeneic transplant recipients at day 0, +14, +30, +60
289 nts with hematologic malignancies undergoing allogeneic transplantation (alloSCT), but its prognostic
290 loablative conditioning regimen (MAC) before allogeneic transplantation in patients with myelodysplas
291 ngiogenesis occurred as early as day+2 after allogeneic transplantation mainly in GVHD typical target
293 stitution is abrogated in both syngeneic and allogeneic transplantation using Treg-depleted mice as r
297 D) is the primary nonrelapse complication of allogeneic transplantation, understanding of its pathoge
299 uced-intensity allogeneic, 113 myeloablative allogeneic) underwent standardized neuropsychologic test
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。